Prostate cancer
Results
Phase 3
This trial looked at combining radium 223 (Xofigo) with best standard care to treat men whose prostate cancer had spread to their bones. This trial recruited men whose cancer was no longer responding to hormone therapy.
Recruitment start: 12 June 2008
Recruitment end: 1 February 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Christopher Parker
Algeta ASA
Bayer Healthcare
Last reviewed: 13 January 2016
CRUK internal database number: 4969